Cargando…
Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions
Numerous new agents with rapid onset antidepressant effects are entering clinical trials and clinical practice. Studies focus on either first-line treatment of major depressive disorder or on patients whose major depressive disorder is resistant to prior antidepressant drugs. Novel agents target thr...
Autores principales: | Cooper, Takesha, Seigler, Michael David, Stahl, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076337/ https://www.ncbi.nlm.nih.gov/pubmed/36988262 http://dx.doi.org/10.1177/02698811231158891 |
Ejemplares similares
-
Applications and future of aptamers that achieve rapid-onset anticoagulation
por: Yu, Haixiang, et al.
Publicado: (2023) -
Agmatine as a novel candidate for rapid-onset antidepressant response
por: Valverde, Ana Paula, et al.
Publicado: (2021) -
Preclinical Evidence of Rapid-Onset Antidepressant-Like Effect in Radix Polygalae Extract
por: Shin, Im-Joon, et al.
Publicado: (2014) -
PS128. Ketamine R(-) and S(+) Pharmacological Actions; Together or Separate Rapid Acting Antidepressants
por: Domino, Edward F.
Publicado: (2016) -
Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant Efficacy
por: Stuart, Sarah A, et al.
Publicado: (2015)